Why choose Medtronic?
We believe your diabetes technology should be working harder to make your life and diabetes management easier.
That’s why we offer many different products — all designed to work harder for you so you can get the outcomes you want and live life your way.
It’s time you ask more of your diabetes technology
When it comes to diabetes technology, we believe it can and should do more for you.
While continuous glucose monitoring (CGM) has become a standard for diabetes care, connecting it with your insulin delivery allows it to go above and beyond simply monitoring. When connected, a CGM can power a system that does more of the thinking, remembering, and acting when it comes to managing diabetes — giving you more freedom to focus on the things that matter.
It works harder, so you don't have to.
Explore systems that do more
Automated Insulin Delivery System
For people who prefer an insulin pump
If you have type 1 diabetes, an insulin pump system could help prevent highs and lows with real-time insulin delivery adjustments 24/7— meaning less work for you!
With an insulin pump system, you get:
- Easier mealtime dosing with Meal Detection™ technology*
- Automatic adjustments and corrections every 5 minutes§
- 96% fewer injections than daily insulin injections**
Smart MDI System
For people who prefer insulin injections
If you manage your diabetes with multiple daily injections (MDI), the smart insulin injection system can help reduce the physical and mental effort required to manage diabetes.
With a Smart MDI system, you get:
- Insulin tracking and dose reminders
- Dosing recommendations
- Actionable glucose alerts
Service and support when you need it
We are committed to providing #ExtraordinaryExperiences for our customers, and are here to assist you with the support you may need every step of the way.
Stories from our #MedtronicChampion community
Engineering the extraordinary in diabetes care
Diabetes management powered by data
We harness data to help make diabetes care more proactive in meeting your specific needs. With technologies that monitor your sugar levels, dosage, and meal history, we transform the information into real-time insights. And by analyzing these insights, we can provide predictions that improve care — leveraging AI to self-adjust and administer the right insulin dose at the right time.
Extraordinary experiences every step of the way
We’re committed to surrounding you and your care partners with exceptional service and support. We’re always ready to help meet your needs 365 days a year. With large teams of therapy specialists and 24/7 customer service just a phone call away, we put you first to deliver an even more seamless experience.
Technology that transforms lives
Diabetes impacts every aspect of life — so our products must also make an impact. That’s why we use our deep understanding of diabetes to engineer life-transforming technologies. With innovations designed to help automate diabetes management, you can focus less on diabetes and more on enjoying life.
* Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to SmartGuard™ feature. Individual results may vary.
** Assumes 4 injections per day for 30 days and one infusion set change every seven days.
Important Safety Information: MiniMed™ 780G System With SmartGuard™ Technology With Guardian™ 4 Sensor
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.
Important Safety Information: i-Port Advance™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. Prescription required. For more, please see http://www.medtronicdiabetes.com/important-safety-information.